相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Static and dynamic F-18-FET PET for the characterization of gliomas defined by IDH and 1p/19q status
Antoine Verger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma
Egesta Lopci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Norbert Galldiks et al.
NEUROIMAGE-CLINICAL (2017)
Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET
Sied Kebir et al.
CLINICAL CANCER RESEARCH (2016)
Early static 18F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans
Nathalie L. Albert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers
Caroline Papin-Michault et al.
PLOS ONE (2016)
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-L-tyrosine PET
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery
Francesco Cicone et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Role of 18F-FDOPA PET/CT imaging in endocrinology
Prasanna Santhanam et al.
CLINICAL ENDOCRINOLOGY (2014)
18F-DOPA, a Clinically Available PET Tracer to Study Brain Inflammation?
Quentin Sala et al.
CLINICAL NUCLEAR MEDICINE (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Comparison of 11C-Methionine, 11C-Choline, and 18F-Fluorodeoxyglucose-Positron Emission Tomography for Distinguishing Glioma Recurrence from Radiation Necrosis
Shunsuke Takenaka et al.
NEUROLOGIA MEDICO-CHIRURGICA (2014)
Bevacizumab for Newly Diagnosed Glioblastoma Reply
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma
Olivier L. Chinot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis
T. Nihashi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Response assessment of bevacizumab in patients with recurrent malignant glioma using [F-18]Fluoroethyl-l-tyrosine PET in comparison to MRI
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comparative diagnostic accuracy of contrast-enhanced MRI and 18F-FDOPA PET-CT in recurrent glioma
Sellam Karunanithi et al.
EUROPEAN RADIOLOGY (2013)
The role of LAT1 in 18F-DOPA uptake in malignant gliomas
Ryan S. Youland et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
[18F]Fluoroethyltyrosine-Positron Emission Tomography-Based Therapy Monitoring after Stereotactic Iodine-125 Brachytherapy in Patients with Recurrent High-Grade Glioma
Nathalie L. Jansen et al.
MOLECULAR IMAGING (2013)
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT
Ferdinando Calabria et al.
NUCLEAR MEDICINE COMMUNICATIONS (2012)
Imaging and response criteria in gliomas
Elizabeth R. Gerstner et al.
CURRENT OPINION IN ONCOLOGY (2010)
Diffusion Magnetic Resonance Imaging Detects Pathologically Confirmed, Nonenhancing Tumor Progression in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
Elizabeth R. Gerstner et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: Initial experience
Carlos J. Ledezma et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Early metabolic responses in temozolomide treated low-grade glioma patients
Matthias Wyss et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas
Elizabeth R. Gerstner et al.
CURRENT OPINION IN NEUROLOGY (2008)
Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas
Florian Stockhammer et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Advances in evaluation of primary brain tumors
Wei Chen et al.
SEMINARS IN NUCLEAR MEDICINE (2008)
The effects of carbidopa on uptake of 6-18F-fluoro-L-DOPA in PET of pheochromocytorna and extraadrenal abdominal paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Cerebral metastases - a therapeutic update
Robert Cavaliere et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas
Katalin Borbely et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
3-O-Methyl-6-[18F]fluoro-L-DOPA and its evaluation in brain tumour imaging
B Beuthien-Baumann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA
RE Yee et al.
BIOCHEMICAL PHARMACOLOGY (2001)
分享论文
